156
Participants
Start Date
December 2, 2019
Primary Completion Date
May 3, 2021
Study Completion Date
May 17, 2021
LC350189 formulated capsule
Xanthine Oxidase Inhibitor
Placebo
Matching placebo
Altoona Center For Clinical Research, Duncansville
Dominion Medical Associates, Richmond
OnSite Clinical Solutions, Charlotte
OnSite Clinical Solutions, Charlotte
Synexus Clinical Research, Anderson
IACT Health, Columbus
Meridien Research, Maitland
Miami Dade Medical Research Institute, Miami
Health Awareness Inc, Jupiter
Clinical Research Trials of Florida, Inc, Tampa
Avita Clinical Trials, Tampa
Meridien Research, St. Petersburg
Synexus Clinical Research, Birmingham
Olive Branch Family Medical Cente, Olive Branch
Synexus Clinical Research, Columbus
Paramount Medical Research and Consulting, Middleburg Heights
Synexus Clinical Research, Akron
Synexus Clinical Research, Cincinnati
Synexus Clinical Research, Richfield
Synexus Clinical Research, Chicago
Synexus Clinical Research, St Louis
Quality Clinical Research, Omaha
Synexus Clinical Research, Omaha
Preferred Research Partner, Little Rock
Synexus Clinical Research, Dallas
Discovery MM Services Incorporated, Houston
Synexus Clinical Research, San Antonio
Avant Research Associates, Austin
Advanced Clinical Research, West Jordan
Synexus Clinical Research, Salt Lake City
Synexus Clinical Research, Mesa
Synexus Clinical Research, Chandler
Synexus Clinical Research, Tucson
Synexus Clinical Research, Henderson
Lead Sponsor
LG Chem
INDUSTRY